Literature DB >> 11528522

Presence of four major haplotypes in human BCMA gene: lack of association with systemic lupus erythematosus and rheumatoid arthritis.

A Kawasaki1, N Tsuchiya, T Fukazawa, H Hashimoto, K Tokunaga.   

Abstract

BCMA (TNFRSF17), along with TACI, has recently been demonstrated to be a receptor for BLyS (TNFSF13B). Recent studies indicated substantial role of BLyS signaling pathway for systemic lupus erythematosus (SLE). In the present study, we made an attempt to screen for polymorphisms of human BCMA, and to test their possible association with SLE and rheumatoid arthritis (RA). Two single nucleotide polymorphisms (SNPs) were detected within the coding sequence, both of which were synonymous substitutions. In addition, two SNPs within the promoter, two SNPs in the 5'-untranslated region (UTR), one SNP and one single nucleotide deletion in the 3'UTR and four rare variations were detected. From the combination of the polymorphisms, it was elucidated that four major haplotypes account for most of the genotypes in the Japanese population. Association with SLE and RA was not detected, although a slight tendency for the increase of BCMA.03 in SLE was observed (P = 0.089). These results indicated that human BCMA is conserved with respect to the amino acid sequence, and evidence for association with SLE and RA was not observed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11528522     DOI: 10.1038/sj.gene.6363770

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  6 in total

Review 1.  Regulatory roles of the tumor necrosis factor receptor BCMA.

Authors:  Christine M Coquery; Loren D Erickson
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

2.  Protein and functional isoform levels and genetic variants of the BAFF and APRIL pathway components in systemic lupus erythematosus.

Authors:  Pilar Ortiz-Aljaro; Marco Antonio Montes-Cano; José-Raúl García-Lozano; Virginia Aquino; Rosario Carmona; Javier Perez-Florido; Francisco José García-Hernández; Joaquín Dopazo; María Francisca González-Escribano
Journal:  Sci Rep       Date:  2022-07-02       Impact factor: 4.996

3.  Genetic associations of leptin-related polymorphisms with systemic lupus erythematosus.

Authors:  Jian Zhao; Hui Wu; Carl D Langefeld; Kenneth M Kaufman; Jennifer A Kelly; Sang-Cheol Bae; Graciela S Alarcón; Juan-Manuel Anaya; Lindsey A Criswell; Barry I Freedman; Diane L Kamen; Gary S Gilkeson; Chaim O Jacob; Judith A James; Joan T Merrill; Patrick M Gaffney; Kathy Moser Sivils; Timothy B Niewold; Michelle A Petri; Seung Taek Song; Hye-Jin Jeong; Rosalind Ramsey-Goldman; John D Reveille; R Hal Scofield; Anne M Stevens; Susan A Boackle; Luis M Vilá; Deh-Ming Chang; Yeong Wook Song; Timothy J Vyse; John B Harley; Elizabeth E Brown; Jeffrey C Edberg; Robert P Kimberly; Bevra H Hahn; Jennifer M Grossman; Betty P Tsao; Antonio La Cava
Journal:  Clin Immunol       Date:  2015-09-16       Impact factor: 3.969

4.  No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome.

Authors:  Jacques-Eric Gottenberg; Jérémie Sellam; Marc Ittah; Frédéric Lavie; Alexis Proust; Habib Zouali; Christelle Sordet; Jean Sibilia; Robert P Kimberly; Xavier Mariette; Corinne Miceli-Richard
Journal:  Arthritis Res Ther       Date:  2006-01-09       Impact factor: 5.156

5.  Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort.

Authors:  Jacques-Eric Gottenberg; Corinne Miceli-Richard; Béatrice Ducot; Philippe Goupille; Bernard Combe; Xavier Mariette
Journal:  Arthritis Res Ther       Date:  2009-07-23       Impact factor: 5.156

6.  Leptin promotes systemic lupus erythematosus by increasing autoantibody production and inhibiting immune regulation.

Authors:  Elaine V Lourenço; Aijing Liu; Giuseppe Matarese; Antonio La Cava
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-01       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.